0001225208-23-003165.txt : 20230302 0001225208-23-003165.hdr.sgml : 20230302 20230302165926 ACCESSION NUMBER: 0001225208-23-003165 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230302 DATE AS OF CHANGE: 20230302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Monson Jonathan CENTRAL INDEX KEY: 0001779170 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 23700041 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORPORATION STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0306 4 2023-03-01 0000885725 BOSTON SCIENTIFIC CORP BSX 0001779170 Monson Jonathan 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 SVP, Global Controller and CAO Common Stock 2023-03-01 4 M 0 5000.0000 12.8900 A 39868.0000 D Common Stock 2023-03-01 4 S 0 5000.0000 46.6630 D 34868.0000 D Stock Option (Right to Buy) 12.8900 2023-03-01 4 M 0 5000.0000 0.0000 D 2024-12-01 Common Stock 5000.0000 5000.0000 D The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.488 to $46.78, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Grant to the reporting person on December 1, 2014, of an option to purchase 17,901 shares of common stock. /s/ Susan Thompson, Attorney-in-Fact 2023-03-02